Swipe to the left

What is the Common Cold?

What is the Common Cold?
1 years ago 7740 Views

The common cold is a viral infection of the upper respiratory tract. Common colds may be caused by over 200 distinct viral pathogens, the most common being rhinovirus, coronavirus, and respiratory syncytial virus. Because there are so many distinct cold-causing viruses, developing immunity against the common cold is unlikely. Infection occurs when the virus comes in contact with mucous membranes (eg, eyes, nose, mouth). Colds generally resolve without treatment, and conventional treatments are mostly palliative and aim to shorten the duration of the illness. An over-the-counter stomach acid medication, cimetidine, may augment the body’s immune response to viral pathogens and prevent colds from setting in.

Natural compounds such as vitamin D and zinc may help prevent the common cold and aid the body’s immune response.

What are Signs and Symptoms?

  • Runny/stuffy nose
  • Sore throat
  • Coughing and sneezing
  • Low-grade fever
  • Mild aches

Note: Cold symptoms are usually mild and resolve within 7–10 days. If symptoms are more severe (eg, high fever, severe body aches), notify a healthcare provider as this may indicate a more serious condition, such as the flu.

What are Ways to Prevent the Common Cold?

  • Avoid contact with others while you have cold symptoms.
  • Direct coughs or sneezes into the crook of your elbow, not your hand or the air.
  • Avoid touching your eyes, nose, and mouth during cold outbreaks.
  • Wash and sanitize hands and surfaces.
  • Exercise regularly.
  • Get adequate sleep (quality and quantity).
  • Take extra around children, as they are more prone to colds. Be strict about hand hygiene and disinfecting surfaces.

What Natural Compounds May Be Beneficial?

  • Vitamin D. Vitamin D has a significant role in regulating the immune system. Daily or weekly supplementation and higher vitamin D levels are associated with a decreased risk of seasonal viral infection and acute respiratory infection.
  • Vitamin C. Vitamin C augments several aspects of the immune system and helps defend against infections. Using vitamin C may reduce the chances of catching a cold and cold duration.
  • Zinc. Zinc deficiency has been linked to immune impairment and susceptibility to infection; supplementation can bolster the body’s ability to fight off viruses. Using zinc within 24 hours of symptom onset may reduce the duration and severity of a cold.
  • Dehydroepiandrosterone (DHEA). DHEA has powerful immune-enhancing and antiviral properties and can increase resistance to many experimental infections. Supplementation in elderly populations is likely to be important, as DHEA declines with age.
  • Melatonin. Melatonin helps combat many types of viral infections. Its administration is associated with increased production of antibodies and like DHEA, may be especially helpful in elderly populations.
  • Elderberry. Elderberry has been used for its beneficial properties since ancient times. Elderberry extracts are used for managing viral infections, such as the common cold.
  • Garlic. Allicin, a compound found in garlic, has demonstrated antiviral activity. Allicin-containing garlic supplements may help prevent viral infection and reduce duration of cold symptoms.
  • Andrographis paniculata. Andrographis paniculata has been used for centuries among Asian cultures to counteract colds. Standardized extracts can reduce symptoms of upper respiratory tract infection and may prevent colds as well.
  • Probiotics. Probiotics may help prevent infection and reduce the risk of catching a common cold. Some probiotics are also associated with reduced severity and duration of symptoms caused by common upper respiratory tract infections.
  • Other natural interventions that may be beneficial include Astragalus membranaceus, lactoferrin, beta-glucan, echinacea, honey, and enzymatically modified rice bran.


The common cold is a viral infection of the upper respiratory tract that causes symptoms such as a runny or stuffy nose, sneezing, coughing, and sore throat (Turner 2009; Turner 2011; Mayo Clinc 2011). Systemic symptoms such as mild headache, fatigue, fever, and muscle aches can occasionally occur with the common cold as well. However, if these symptoms are severe and/or accompanied by fever or significant exhaustion, they likely indicate the "flu", which is a distinct type of viral respiratory infection caused by an influenza virus (CDC 2011; Hayden 2011; NIAID 2011a).

Although most cases of the common cold are mild and self-limiting, the illness represents a major economic burden to society in terms of lost productivity and treatment expenditure (Maggini 2012; Lissiman 2012; Turner 2009).

Treatment strategies for the common cold are generally aimed at relieving symptoms, shortening duration, and minimizing the risk of complications (Roxas 2007; Albalawi 2011).Conventional cold treatments include over-the-counter analgesics and decongestant medications (Roxas 2007; NIH 2012b). However, these strategies are minimally effective (Nahas 2011), and even when used appropriately, may be associated with significant side effects (Shefrin 2009).

Several innovative and integrative strategies such as vitamin D, garlic, zinc, Astragalus, beta glucan, and probiotics have been shown in scientific studies to provide support for immune challenges. (Maggini 2012).

2019 Novel Coronavirus

Over the last few decades, several new viruses have emerged as threats to human health around the globe. The most recent example is 2019 novel coronavirus, or 2019-nCoV.

2019-nCoV came to the attention of health authorities when it was identified as the cause of a small number of pneumonia cases in the city of Wuhan in Hubei province, China (WHO 2020). Since then, thousands of cases of 2019-nCoV illness have been identified in China, mainly in Hubei province, and international spread has been reported as travelers coming from China carry the virus worldwide (CDC 2020a).


Coronaviruses are a large group of related viruses that cause many common human and animal infections (Li 2020). In humans, coronaviruses typically cause mild respiratory infections. Responsible for an estimated 10–30% of all upper respiratory tract infections, coronaviruses are among the most frequent causes of the common cold (Paules 2020). Over the last decade, new coronaviruses that cause potentially lethal respiratory diseases have emerged. These include severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (Su 2016).

The SARS pandemic, which lasted about nine months in 2002–2003, affected over 8,000 people in 29 world regions and caused fatality in almost 10% of cases. MERS, on the other hand, has been smoldering mainly on the Arabian Peninsula since 2012, infecting approximately 2,400 people and having a case fatality rate of nearly 35% (Hui 2020; Killerby 2020). For perspective, the fatality rate of influenza virus is typically much lower, reaching a maximum of about 0.2% in people over 75 years old; however, because of its high incidence, the number of deaths attributable to the flu worldwide averages between 291,000 and 646,000 annually (Iuliano 2018).

Although the characteristics of 2019-nCoV illness are still being elucidated, those most likely to contract 2019-nCoV are those in direct contact with other infected individuals. The most common presentation is fever and cough followed by flu-like symptoms, with rapid progression to fulminant pneumonia and death mainly in those over 70 years old. So far, the case fatality rate is 2.94% (Wang 2020). Experience with other new coronavirus outbreaks suggests those at greatest risk, in addition to the elderly, are likely to be those who are hospitalized, immunocompromised, or have a chronic disease (Hui 2020; Azhar 2019). In addition, health care workers have historically been at increased risk of developing and transmitting coronavirus infections (Judson 2019; Otter 2016).


Coronaviruses are highly adaptable and known to undergo host-switching. Several established human coronaviruses have evolved from bird or mammalian coronavirus origins (Corman 2018). For example, the human coronavirus associated with MERS is likely to have come from camels, though its origins may have been a bat coronavirus; the SARS coronavirus also appears to have originated in bats and was possibly transmitted by an intermediate mammalian host called a civet (Azhar 2019; Hui 2019). Although distinct from all other known coronaviruses, 2019-nCoV also appears to be closely related to a bat coronavirus (Chen 2020).

Once adapted to the human host, coronaviruses can become transmissible between humans. There are four possible routes of transmission: contact, droplet, aerosol, and oral-fecal (Shiu 2019).

  • Contact. Direct contact is the most likely route of transmission for coronaviruses such as those associated with SARS, MERS, and the current outbreak (Killerby 2020). In these cases, the virus is transferred when an uninfected individual comes into direct contact with an infected person who is actively shedding virus.
  • Droplet. In this form of viral spread, the virus is suspended in droplets emitted from the respiratory tract of an infected individual through a sneeze or cough and inhaled by nearby uninfected individuals. Another possibility is that droplets may land on or near uninfected individuals, be picked up by hands, and transferred to the respiratory tract through touching the nose, mouth, or eyes (Hui 2019). Interestingly, studies using SARS and MERS coronaviruses show they can remain viable on inanimate surfaces for long periods of time, even months, depending on the nature of the surface and environmental conditions (Otter 2016).
  • Aerosol. The aerosol route of transmission involves inhalation of airborne viruses, possibly at some distance from the infected person. Although this is less likely than direct contact or droplet transmission, studies in indoor environments and some case reports suggest this is a viable transmission route for SARS and MERS coronaviruses (Judson 2019; La Rosa 2013). Aerosol transmission appears to be an especially important concern in health care settings where aerosol-generating medical procedures may put health care workers and other patients at risk (Judson 2019).
  • Oral-fecal. The oral-fecal route involves viruses being shed through the feces (usually in people with diarrhea), contaminating surfaces and ultimately hands that can then introduce the virus to the respiratory tract. This is an uncommon but documented route of transmission for coronaviruses such as the SARS virus (Hui 2019).

Protective Measures

Below are some basic measures to consider in order to reduce your risk of contracting 2019-nCoV and other viral illnesses.

1. Avoid air travel to affected regions. Avoiding contact with infected individuals is the best way to protect yourself from 2019-nCoV. Therefore, avoiding it is a reasonable precaution for reducing your risk of viral infections in general, particularly if you have other vulnerabilities.

2. Wash your hands. Frequent hand washing is an important strategy for protecting against all types of infectious diseases. Studies in office and health care settings have further demonstrated strategic use of alcohol-based surface disinfectants and hand sanitizers can reduce viral spread by 85–94% (Kurgat 2019; Reynolds 2019).

3. Strengthen immunity. Optimal functioning of the immune system is vital for defending against all types of infections, from mild colds to dangerous influenza and life-threatening pneumonia. A nutrient-dense diet, regular exercise, adequate sleep, and stress management can all contribute to healthy immune function (Zapatera 2015).

4. Consider a face mask. Findings from several studies suggest face masks, when used correctly, might slow the spread of viral infection by reducing infection risk in well people (MacIntyre 2015). One model of viral spread in a healthcare setting estimated face masks could reduce flu susceptibility by 3–10% (Blanco 2016). Face masks may work in part by inhibiting droplet spread and reducing touching of the nose and mouth with contaminated hands (Qualls 2017). It is also possible face mask-wearing by sick individuals may protect those in proximity, but the evidence to support this notion is sparse (Qualls 2017; MacIntyre 2016).

5. Disinfect surfaces. Coronaviruses can persist on inanimate surfaces like metal, glass, or plastic for up to nine days. Fortunately, coronaviruses can be inactivated with proper cleaning and disinfecting agents. Therefore, keeping surfaces clean and properly disinfected is important to limit the spread of infectious diseases caused by coronaviruses. A study published on February 6, 2020 found that coronaviruses on inanimate surfaces can be inactivated within one minute through disinfection with 62-71% ethanol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite (eg, bleach) (Kampf 2020).


Because there are no proven medical treatments for 2019-nCoV or other human coronaviruses, scientists are looking to both old and new antiviral drugs in search of effective therapies. Some, but not all, laboratory, animal, and preliminary human trials exploring the use of established antiviral medications against human coronaviruses have reported positive findings.

Remdesivir is another antiviral drug that has shown promise against 2019-nCoV in preliminary pre-clinical studies. It is a prodrug of an adenosine analog that has potent antiviral activity against many RNA virus families (Agostini 2018). A 2018 in vitro study showed that remdesivir was efficacious against two strains of human endemic coronavirus (HCoV-OC43 and HCoV-229E) (Brown 2019).

In the face of low efficacy and challenging adverse side effects of known medications, researchers are searching for new approaches. Immunotherapy using monoclonal antibodies could have a role in treating MERS, SARS, and other emerging coronavirus infections such as 2019-nCoV illness (Jin 2017), and novel compounds with anti-coronavirus activity are currently being developed and tested (Sheahan 2017).

Development and Progression of the Common Cold

While the common cold may be caused by over 200 distinct and continually evolving viral pathogens; rhinoviruses, coronaviruses and respiratory syncytial viruses appear to be some of the most common (Turner 2009; Nussenbaum 2010; Worrall 2011; CDC 2012C).

Infection occurs when the cold-causing virus comes into contact with mucous membranes in the nose or eyes. Common cold infections generally result in a non-specific acute inflammatory response that stimulates the release of various inflammatory cytokines and other immune mediators. In fact, many of the symptoms associated with the common cold are a result of inflammation caused by this immune response, rather than by the virus itself (Turner 2009; Turner 2011; Hayden 2011; Pappas 2009). For example, the release of a proinflammatory peptide called bradykinin is a major contributor to sore throat symptoms (Turner 2009; Proud 1988). Stuffy nose symptoms result from increased pooling of blood in nasal blood vessels and increased nasal secretions. Likewise, runny nose occurs due to enhanced permeability of nasal blood vessels, which allows serum to leak into the nasal mucosa (Turner 2011).

Although infection with a virus known to cause the common cold generates an adaptive immune response that helps protect against repeated infection by the same or very similar virus, the sheer volume of distinct viruses that can cause the common cold makes developing immunity against the common cold itself very challenging (Hayden 2011; Turner 2009, Turner 2011). However, infection by a cold virus can decrease the risk and severity of re-infection with the same virus (Turner 2009).

Common Cold Symptoms

The clinical symptoms of the common cold generally occur within 24-72 hours of infection, and typically begin with a runny nose and a sore or "scratchy" throat. Sore throat symptoms usually subside by the 2nd or 3rd day of infection, after which nasal symptoms typically become the most bothersome (Turner 2009; Turner 2011; Hayden 2011; Nussenbaum 2010). Three out of every 10 people with the common cold may develop an unproductive cough, often beginning after the onset of nasal symptoms, and persisting as the cold resolves (Turner 2009; Turner 2011; Hayden 2011; Nussenbaum 2010). As a whole, these symptoms may last anywhere from 2 to 14 days, but most people recover within 7 to 10 days. Nasal symptoms lasting longer than 2 weeks may be due to seasonal allergies rather than the common cold (NIAID 2011b).

Occasionally, common cold infections are associated with other complications such as ear and/or sinus infection. The common cold has also been known to exacerbate certain diseases of the upper respiratory tract such as asthma, bronchitis, cystic fibrosis, and COPD. Patients who experience high fever, intense sinus pain, severely swollen glands, and/or cough that produces mucus (i.e., productive cough) may have a more serious illness, and should notify their health care provider immediately (NIAID 2011b; Turner 2011; Roxas 2007d; Niespodziana 2012).

Common Cold vs. The Flu: Comparison of Characteristics




Etiological Agent

>200 viral strains; rhinovirus most common

3 strains of influenza virus: influenza A, B, and C

Site of Infection

Upper respiratory tract

Entire respiratory system

Symptom Onset

Gradual: 1-3 days

Sudden: within a few hours

Fever, chills

Occasional, low grade (<101° F)

Characteristic, higher (>101° F),

lasting 2-4 days


Infrequent, usually mild

Characteristic, more severe

General aches, pains

Mild, if any

Characteristic, often severe and affecting the entire body

Sore throat

Common, usually mild

Sometimes present

Cough, chest congestion

Common; mild-to-moderate, with hacking, productive cough

Common; potentially severe dry, non-productive cough

Runny, stuffy nose

Very common, accompanied by bouts of sneezing

Sometimes present

Fatigue, weakness

Mild, if any

Usual, may be severe and last 2-3 weeks

Extreme exhaustion


Frequent, usually in early stages of illness


Year around, peaks in winter months

Most cases between November and February

Antibiotics helpful?

No, unless secondary bacterial infection develops

No, unless secondary bacterial infection develops

(Roxas 2007; MD Consult 2012c; Utah Dept. Health 2010; CDC 2011; Oklahoma State Dept. of Health 2011)

Common Cold Prevention

Suggestions for preventing the common cold include:

Avoid others while you have cold symptoms and are contagious (i.e., 2-7 days) - Depending on the offending virus, the common cold may be transmitted from one person to another via inhalation. This is because viral particles are small enough to be suspended in the air when an infected person coughs, sneezes, or blows their nose. Since some viruses can live for up to 3 hours on human skin, the cold can also be transmitted via direct contact with an infected person (NIAID 2011c; Turner 2011; NIH 2012A).

Infected individuals should direct their cough or sneeze into the inner crook of their elbow, rather than into their hand(s) or directly into the air - The contagious particles from a cough or sneeze occasionally land on environmental objects or surfaces, where rhinoviruses can also survive for up to 3 hours (NIH 2012a; Nicas 2008; NIAID 2011c).

Avoid touching eyes, nose, and/or mouth during cold outbreaks - For most people this task is extremely difficult, especially since the average person touches their face approximately 16 times per hour. Given that unconscious face touching is almost unavoidable, hand washing/sanitizing and using surface disinfectants to prevent the spread of the common cold is important (NIH 2012a; Nicas 2008; NIAID 2011c).

Lifestyle modifications such as exercising have proven to be effective at reducing the number of common cold infections (NIAID 2011c). Individuals who become infected with mild to moderate cases of the cold should continue their exercise routine, provided their symptoms are not body-wide (Simon 2012).

Adequate sleep quantity and quality are important for protecting against common cold – Sleep is known to modulate the immune responses through the production of regulatory cytokines (Teodorescu 2012; Walsh 2011).

When possible, limit your exposure to children (particularly via day-care centers) during peak cold season – Since children are much more likely to contract a cold than adults (6-8 colds/yr. vs. 2-4 colds/yr., respectively), the adult risk of infection increases with increased contact with children, especially in close quarters (Lissiman 2012; Turner 2009). If this cannot be avoided, you should take extra precautions to wash/sanitize your hands and disinfect surfaces that may be contaminated (NIH 2012a; Nicas 2008; NIAID 2011c).

Targeted Nutritional Support

After infection, viruses causing the common cold multiply rapidly. While most people wait until their symptoms become unbearable, then use an over-the-counter medication, an possibly superior alternative is to take aggressive action when the viral count is still relatively low and symptoms are mild.

Vitamin D. Evidence suggests vitamin D has a significant role in the regulation of the human immune system, and may reduce the risk of certain bacterial and viral infections (Beard 2011; Grant 2010). Furthermore, data show that higher vitamin D levels are associated with a decreased risk of contracting a seasonal viral infection (Berry 2011; Cannell 2011). In a comprehensive review, researchers analyzed data from 10,933 participants in 25 randomized controlled trials looking at the effect of vitamin D on risk of acute respiratory infections, including common colds. The analysis found that those receiving daily or weekly vitamin D supplements, in doses ranging from 300 IU to 4000 IU per day, had a 19% reduction in acute respiratory infection risk, and those with vitamin D deficiency (levels below 25 nmol/L or 10 ng/mL) at the beginning of the trial experienced a greater protective effect. A risk reduction was not seen in participants who received individual large doses of vitamin D (30,000 IU or more), either once or at intervals of one to three months, whether alone or in addition to daily or weekly doses (Martineau 2017). Life Extension recommends an optimal 25-hydroxyvitamin D blood level of between 50 and 80 ng/ml.

Vitamin C. Evidence shows that vitamin C augments several aspects of the immune system and helps defend against infections (especially viral infections) (Ely 2007; Holt 2010; Heimer 2009; Khalid 2011). Vitamin C enhances the production and action of white blood cells; for example it increases the ability of neutrophils (a type of white blood cell) to attack and engulf viruses (Heimer 2009; Jariwalla 1996; Anderson 1984). Vitamin C has been shown to reduce the chances of catching a cold, and may reduce cold duration (Holt 2010; Hemila 2011). Upon review of clinical data from 2 studies, researchers found that using vitamin C (1000 mg) plus zinc (10 mg) during a cold could reduce runny nose symptoms by up to 27 % over 5 days of treatment compared to placebo (Maggini 2012).

Zinc – Zinc helps maintain a healthy immune system, and zinc deficiency has been linked to significant immune impairment and susceptibility to infections (Roxas 2007; Maggini 2012). Unfortunately, zinc deficiency is a common problem affecting approximately 2 billion people worldwide, even many people in Western populations. Correcting zinc deficiency through supplementation has been shown to bolster aspects of the immune system involved in fighting viral infections (Maggini 2012; Sandstead 2010; Pae 2012). Zinc's antiviral properties may come from its ability to prevent the rhinovirus from attaching to cells in the nasal passages. In addition, zinc has been shown to prevent viral replication, reduce histamine release, and inhibit the production of other inflammatory mediators (Singh 2011).

A comprehensive review concluded that zinc supplementation was associated with a significant reduction in the duration and severity of the common cold (when administered within 24 hours of onset of symptoms). It was also found that zinc supplementation over 5 months was helpful for preventing the common cold (Singh 2011). Life Extension Magazine® published a comprehensive overview of the evidence suggesting that zinc acetate lozenges dissolved in the mouth every two waking hours may be an ideal approach during the early stages of the common cold.

DHEA. Dehydroepiandrosterone (DHEA) is a steroid hormone synthesized by the adrenal gland. Research has revealed that DHEA possesses powerful immune-enhancing and antiviral properties, and can enhance resistance to many different experimental infections (Romanutti 2010; Torres 2012; Kuehn 2011; Roxas 2007). DHEA accomplishes this in part by modulating several aspects of the immune system. For example, administering 50 mg of DHEA daily to an elderly population resulted in an increase in natural killer cell activity, a 62% increase in B cell activity and a 40% increase in T cell activity, all of which are important for defending against infectious pathogens (Roxas 2007).

DHEA supplementation is likely to be especially important among the aging and elderly, since DHEA levels decline sharply with age (Roxas 2007; Khorram 1997).

Melatonin. Melatonin is a hormone produced in the brain and the gut. It helps regulate the sleep-wake cycle and is a powerful antioxidant. Research indicates that melatonin helps combat many types of viral infections (Srinivasan 2012; Arushanian 2002; Boga 2012). For example, melatonin appears to "prime" the immune system by interacting with specialized immune cells called "T-helper cells", allowing for a more efficient immune response against pathogens. Furthermore, melatonin administration is also associated with an increased production of antibodies (Bonilla 2004).

Melatonin's role as an antioxidant may be helpful during a cold as well, since most viral infections are associated with high amounts of oxidative stress (Boga 2012). This may be especially true for elderly populations, since these patients frequently experience age-related impairment of the immune system, which coincides with declining melatonin concentrations (Srinivasan 2005).

Astragalus membranaceus. Astragalus membranaceus is a Chinese herb that contains a number of immune-stimulating ingredients such as polysaccharides, flavonoids, trace minerals, and amino acids. While it has been traditionally used to treat colds and flu as well as for increasing stamina and overall vitality, much of the research performed on Astragalus membranaceus is focused on its application for treating immune deficiency conditions (Roxas 2007; AMR 2003). In a clinical study comparing various natural products (i.e., echinacea, astragalus membranaceus, and licorice), Astragalus membranaceus demonstrated the strongest ability to activate immune cells (Roxas 2007).

Elderberry. Elderberry, also known as Sambucus nigra, has been used for its medicinal properties since at least 400 BC (Krawitz 2011; Roxas 2007). The purplish-black fruits of the elderberry plant are a rich source of antioxidants, and have long been considered a folk remedy for the treatment of influenza as well as the common cold (Ozgen 2010; Zakay-Rones 2004). Even today, elderberry extracts are commonly employed as an alternative to conventional drugs for the management of a variety of viral infections and are recognized as supportive agents against common cold (Krawitz 2011). Researchers believe that elderberry fights colds by activating white blood cells that engulf pathogens. The German Commission E (a therapeutic guide for the safety and efficacy of herbal products) has identified the constituents of elderberry as effective for the relief of colds (Roxas 2007).

Garlic. Garlic (i.e., allium sativum) has been traditionally used for both its culinary and therapeutic properties (Lissiman 2012). A clinical survey found that garlic is one of the most common herbs used for its medicinal properties including for the treatment of colds, flu, and cough (Zhang 2008). When raw garlic is chopped or chewed, it releases an active organo-sulfur compound called allicin, which has demonstrated antiviral activity against rhinovirus and a variety of other pathogens (Nahas 2011). While studies evaluating the use of garlic/allicin for the treatment of the common cold are lacking, evidence suggests it may be useful for the prevention of such infections (Nahas 2011). For example, one clinical study demonstrated that an allicin-containing garlic supplement taken once daily (over a 12-week period) was associated with 65% fewer colds than the placebo group (24 vs. 65). When compared to placebo, garlic/allicin supplementation was also linked to 70% reduction in symptom duration (~ 1.5 vs. 5 days) (Josling 2001).

Andrographis. Andrographis paniculata has been effectively used among Asian cultures for the treatment of colds for centuries (Chandrasekaran 2009; Ozolua 2011; Ji 2005; Akbar 2011; Valdiani 2012). It is reported to have anti-inflammatory, blood pressure lowering, antiviral, and immune-stimulant properties (Yang 2010). A 2009 study found that an extract of Andrographis enhanced immune function as well as reversed drug-induced immunosuppression (Naik 2009). Accumulating evidence suggests that Andrographis paniculata is effective as an alternative treatment option for the common cold (Coon 2004; Poolsup 2004; Kligler 2006). For example, a 2010 study found that a standardized extract of Andrographis paniculata was more than twice as effective as placebo in reducing symptoms of upper respiratory tract infections (Saxena 2010). Preliminary evidence suggests that Andrographis paniculata may be effective for the prevention of colds as well (Coon 2004).

Lactoferrin. Lactoferrin is an iron-binding protein found in milk. It is a powerful immune modulator and has shown marked ability to fight bacteria, fungi, protozoa, and viruses (Roxas 2007; Orsi 2004; Lonnerdal 2009). Laboratory studies reveal lactoferrin inhibits viral infection by interfering with the ability of certain viruses to bind to cell receptor sites and prevents entry of viruses into host cells (Waarts 2005; Berlutti 2011). In addition, lactoferrin may be beneficial for alleviating the symptoms or complications of viral infections like the common cold, because it suppresses free radical-mediated damage (Roxas 2007).

Beta-glucan. Beta-glucans are naturally occurring glucose polymers that constitute the cell walls of certain plants and pathogenic agents (Akramiene 2007). These polysaccharides have been shown to increase host immune defense, and are associated with enhancing macrophage and natural killer cell function (Pence 2012; Akramiene 2007). Beta glucans also appear to mitigate the symptoms of the common cold. The Montana Center for Work Physiology and Exercise Metabolism examined beta glucans' ability to mitigate upper respiratory infections in a single blind, randomized trial in 2008. Participants who consumed beta-glucans had 23% fewer upper respiratory tract infections, compared to the group taking a placebo (PRNewswire 2008).

Probiotics. Probiotics are defined as living microorganisms (i.e., bacteria and fungi) that confer a health benefit to the host when administered in adequate amounts (Gilliland 2001; MacDonald 2010). Clinical studies suggest that certain probiotics may help prevent viral respiratory tract infections such as the common cold by enhancing the immune system. Some probiotics are associated with a reduction in severity and duration of symptoms caused by common upper respiratory tract infections (de Vrese 2008; MacDonald 2010; Wolvers 2010; Vouloumanou 2009; Baron 2009; Leyer 2009). Probiotics may be useful for managing infectious diseases because of their potential for stabilizing the micro-flora of the gut, enhancing resistance against pathogenic colonization, and modulating immune functions (Wolvers 2010; Kimmel 2010; Baron 2009). A 2011 clinical study found that a probiotic lactobacilli was able to strengthen the body's immune defense against viral infections and reduce the risk of acquiring the common cold (Berggren 2011). Furthermore, the consumption of yogurt fermented with Lactobacillus augmented natural killer cell activity and reduced the risk of catching common cold infections among the elderly (Makino 2010).

Echinacea. Echinacea is an herb that was first utilized for its medicinal value by the Native Americans in the treatment of cough, sore throat, and tonsillitis (Caruso 2005). Today, echinacea represents one of the most popular herbs used for the treatment and prevention of upper respiratory tract infections (like the common cold) in both European and American markets (Tierra 2007; Woelkart 2008; Toselli 2009). Clinical evidence shows that echinacea has beneficial effects on the common cold, including reduced severity and duration of cold symptoms, as well as increases in monocytes, neutrophils, natural killer (NK) cells, and total white blood cell count (Roxas 2007). A 2010 clinical study found that a standardized extract of E. purpurea was able reduce the risk of common cold among athletes (Ross 2010).

Honey. Honey has been used since ancient times as a cough and cold remedy in some countries (Pourahmad 2009). Studies have shown that honey possesses antimicrobial properties and helps combat infection in a variety of clinical settings (Al-Waili 2011). Clinical trials have compared the efficacy of honey to that of placebo and several conventional medicines for relieving symptoms of the common cold (Pourahmad 2009). Evidence suggests that honey can relieve symptoms of the common cold in adults and children more effectively than some, but not all, conventional medicines (Heppermann 2009; Paul 2007; Oduwole 2012; Cohen 2012).

Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the therapies discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

Summary & Quick Facts

  • The common cold is a leading cause of medical visits and missed days at work or school.
  • Treatment strategies for the common cold are generally aimed at relieving symptoms, shortening duration and minimizing the risk of complications.
  • Several innovative and integrative strategies such as vitamin D, garlic, zinc, astragalus, beta glucan and probiotics have been shown in scientific studies to help manage symptom duration and intensity associated with the common cold.


Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, . . . Denison MR. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio. 2018;9(2):e00221-00218.

Akbar S. Andrographispaniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. 2011;16(1):66-77.

Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E. Effects of beta-glucans on the immune system. Medicina. 2007;43(8):597-606.

Albalawi ZH, Othman SS, Alfaleh K. J Med Food. 2011 Oct; 14(10): 1079-96.

AMR. Astragalusmembranaceus.Monograph.Altern Med Rev. 2003;8(1):72-77.

Anderson R. The Immunostimulatory, Antiinflammatory and Anti-Allergic Properties of Ascorbate. [In eng] AdvNutr Res. 1984 6(19-45.

Arae K, Oboki K, Ohno T, et al. Cimetidine enhances antigen-specific IgE and Th2 cytokine production. Allergol Int. 2011;60(3):339-344.

Arushanian EB, Beier EV. [Immunotropic properties of pineal melatonin].EkspKlinFarmakol. 2002;65(5):73-80.

Atkins D. (2011) Chapter 136: Principles of Treatment of Allergic Disease (pg. 768). In: Kliegman R. (Ed.), Nelson Textbook of Pediatrics (19th ed.) Saunders, An Imprint of Elsevier.

Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East Respiratory Syndrome (MERS). Infect Dis Clin North Am. 2019;33(4):891-905.

Barlow PG, Svoboda P, Mackellar A, et al. Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin Ll-37. [In eng] PLoS One. 2011 6(10): e25333.

Baron M. A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med. 2009;121(2):114-118.

Barrett B, Harahan B, Brown D, Zhang Z, Brown R. Sufficiently important difference for common cold: severity reduction. Ann Fam Med. 2007;5(3):216-223.

Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J ClinVirol. 2011;50(3):194-200.

Berggren A, LazouAhren I, Larsson N, Onning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2011;50(3):203-210.

Berlutti F, Pantanella F, Natalizi T, et al. Antiviral Properties of Lactoferrin--a Natural Immunity Molecule. [In eng] Molecules. 2011 16(8): 6992-7018.

Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr. 2011;106(9):1433-40.

Blanco N, Eisenberg MC, Stillwell T, Foxman B. What Transmission Precautions Best Control Influenza Spread in a Hospital? Am J Epidemiol. 2016;183(11):1045-1054.

Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ. Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"? Rev Med Virol. 2012;18(10).

Bonilla E, Valero N, Chacin-Bonilla L, Medina-Leendertz S. Melatonin and viral infections. J Pineal Res. 2004;36(2):73-79.

Brown AJ, Won JJ, Graham RL, Dinnon KH, 3rd, Sims AC, Feng JY, . . . Sheahan TP. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral research. 2019;169:104541-104541.

Cannell JJ, Hollis BW. Use of vitamin D in clinical practice.Altern Med Rev. 2008;13(1):6-20.

Cannell JJ. The difference between a prophet and a madman.Br J Nutr. 2011;106(9):1317-8.

Caruso TJ, Gwaltney JM, Jr. Treatment of the common cold with echinacea: a structured review. Clin Infect Dis. 2005;40(6):807-810.

CDC (Centers for Disease Control and Prevention) Antibiotics Aren't Always the Answer. Last updated Feb. 27, 2012b. Accessed 7/25/12 at: http://www.cdc.gov/Features/GetSmart/

CDC (Centers for Disease Control and Prevention). Cold Versus Flu. 2/8/2011. Available at: http://www.cdc.gov/flu/about/qa/coldflu.htm. Accessed 8/24/2012.

CDC. Centers for Disease Control and Prevention. 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. Available at https://www.cdc.gov/coronavirus/2019-ncov/summary.html. Last undated January 28, 2020a. Accessed January 29, 2020.

CDC. Center for Disease Control and Prevention. Travelers’ Health: China Traveler View. Available at https://wwwnc.cdc.gov/travel/destinations/traveler/none/china. Last updated 01/27/2020b. Accessed 01/30/2020.

CDC. Common Cold and Runny Nose. 5/1/2012a. Available at: http://www.cdc.gov/getsmart/antibiotic-use/URI/col... Accessed 8/24/2012.

Chandrasekaran CV, Thiyagarajan P, Sundarajan K, et al. Evaluation of the genotoxic potential and acute oral toxicity of standardized extract of Andrographispaniculata (KalmCold). Food ChemToxicol. 2009;47(8):1892-1902.

Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020.

Chesler DA, Reiss CS. The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine & growth factor reviews.Dec 2002;13(6):441-454.

Choi JY, Paik DJ, Kwon DY, Park Y. Nutrition journal.2014;13:35.

Cholujova D, Jakubikova J, Sedlak J. BioBran-augmented maturation of human monocyte-derived dendritic cells. Neoplasma.2009;56(2):89-95.. Thorax. 2004;59(3):252-256.

Clinical Pharmacology. (2012a) Diphenhydramine: drug monograph.

Clinical Pharmacology. (2012b) Dextromethorphan: drug monograph.

Cohen HA, Rozen J, Kristal H, et al. Effect of Honey on Nocturnal Cough and Sleep Quality: A Double-Blind, Randomized, Placebo-Controlled Study. [In Eng] Pediatrics. 2012 Aug 6;

Connor S. A cure for the common cold may finally be achieved as a result of a remarkable discovery in a Cambridge laboratory. 11/2/2010. Available at: http://www.independent.co.uk/news/science/a-cure-f... Accessed 8/30/2012.

Coon JT, Ernst E. Andrographispaniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med. 2004;70(4):293-298.

Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res. 2018;100:163-188.

De Sutter AI, Lemiengre M, Campbell H. WITHDRAWN: Antihistamines for the common cold. Cochrane Database Syst Rev. 2009;7(4).

de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. AdvBiochemEngBiotechnol. 2008;111:1-66.

Dealleaume L, Tweed B, Neher JO. Do OTC remedies relieve cough in acute URIs? J FamPract. 2009;58(10):559a-c.

Dyall J, Gross R, Kindrachuk J, et al. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies. Drugs. 2017;77(18):1935-1966.

Ely JT. Ascorbic acid role in containment of the world avian flu pandemic.ExpBiol Med. 2007;232(7):847-851.

Erebara A, Bozzo P, Einarson A, Koren G. Treating the common cold during pregnancy. Can Fam Physician. 2008;54(5):687-689.

EvaluatePharma. Biota Announces Positive Phase IIb Data for Asthmatic Patients With Human Rhinovirus Infection (HRV). March 28, 2012. Available at: http://www.evaluatepharma.com/Universal/View.aspx?... Accessed 8/30/2012.

Ghoneum M, Abedi S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). The Journal of pharmacy and pharmacology.Dec 2004;56(12):1581-1588.

Ghoneum M, Agrawal S. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran). International journal of immunopathology and pharmacology.Oct-Dec 2011;24(4):941-948.

Ghoneum M, Agrawal S. Mgn-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells. International journal of immunopathology and pharmacology.Oct-Dec 2014;27(4):523-530.

Ghoneum M, Jewett A.. Cancer detection and prevention.2000;24(4):314-324.

Ghoneum M, Matsuura M. Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). International journal of immunopathology and pharmacology. Sep-Dec 2004;17(3):283-292.

Ghoneum M, Matsuura M, Gollapudi S. Modified arabinoxylan rice bran (MGN3/Biobran) enhances intracellular killing of microbes by human phagocytic cells in vitro. International journal of immunopathology and pharmacology.Jan-Mar 2008;21(1):87-95.

Giese S, Sabell GR, Coussons-Read M. Impact of ingestion of rice bran and shitake mushroom extract on lymphocyte function and cytokine production in healthy rats. Journal of dietary supplements.2008;5(1):47-61.

Gilliland SE, Morelli L, Reid G. Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Rome, Italy: Food and Agriculture Organization of the United Nations World Health Organization; 2001. Available at: ftp://ftp.fao.org/es/esn/food/probio_report_en.pdf. Accessed July 19, 2012

Grant WB, Goldstein M, Mascitelli L. Ample evidence exists from human studies that vitamin D reduces the risk of selected bacterial and viral infections. ExpBiol Med. 2010;235(12):1395-1396.

Harthill M. Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol Trace Elem Res. 2011;143(3):1325-1336.

Hayden G. (2011) Chapter 371: The Common Cold (pg. 1434). In: Kliegman R. (Ed.), Nelson Textbook of Pediatrics (19th ed.) Saunders, An Imprint of Elsevier.

Heimer KA, Hart AM, Martin LG, Rubio-Wallace S. Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold. J Am Acad Nurse Pract. 2009;21(5):295-300.

Hemila H. The effect of vitamin C on the common cold: J Pharm Pract. 2011 Apr;24(2):241-2.

Heppermann B. Towards Evidence Based Emergency Medicine: Best Bets from the Manchester Royal Infirmary. Bet 3. Honey for the Symptomatic Relief of Cough in Children with Upper Respiratory Tract Infections. [In eng] Emerg Med J. 2009 Jul; 26(7): 522-3.

Hertzberg VS, Weiss H. On the 2-Row Rule for Infectious Disease Transmission on Aircraft. Ann Glob Health. 2016;82(5):819-823.

Holt S. Hype around high-dose vitamin C is unjustified: N Z Med J. 2010 Oct 15;123(1324):109-10.

Hsu CH, Hwang KC, Chao CL, et al. An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study. Evid Based Complement Alternat Med. 2008;5(3):355-362.

Hsu S. Compounds Derived from Epigallocatechin-3-Gallate (EGCG) as a Novel Approach to the Prevention of Viral Infections. Inflamm Allergy Drug Targets. 2015;14(1):13-18.

Hui DS, E IA, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-266.

Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019;33(4):869-889.

Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-1300.

Jariwalla RJ, and Harakeh S. Antiviral and Immunomodulatory Activities of Ascorbic Acid. [In eng] SubcellBiochem. 1996 25(213-31.

Ji LL, Wang Z, Dong F, Zhang WB, Wang ZT. Andrograpanin, a compound isolated from anti-inflammatory traditional Chinese medicine Andrographispaniculata, enhances chemokine SDF-1alpha-induced leukocytes chemotaxis. J Cell Biochem. 2005;95(5):970-978.

Jin Y, Lei C, Hu D, Dimitrov DS, Ying T. Human monoclonal antibodies as candidate therapeutics against emerging viruses. Front Med. 2017;11(4):462-470.

Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. AdvTher. 2001;18(4):189-193.

Judson SD, Munster VJ. Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures. Viruses. 2019;11(10).

Kaihatsu K, Yamabe M, Ebara Y. Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters. Molecules. 2018;23(10).

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. The Journal of hospital infection. 2020:S0195-6701(0120)30046-30043.

Khalid U, Saleem T, Shah S. Therapeutic and prophylactic use of vitamin C for the common cold: J Pak Med Assoc. 2011 Dec;61(12):1252.

Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A BiolSci Med Sci. 1997;52(1):M1-7.

Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East Respiratory Syndrome Coronavirus Transmission. Emerg Infect Dis. 2020;26(2):191-198.

Kimmel M, Keller D, Farmer S, Warrino DE. A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers. Methods Find ExpClinPharmacol. 2010;32(2):129-132.

Kligler B, Ulbricht C, Basch E, et al. Andrographispaniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration. Explore. 2006;2(1):25-29.

Krawitz C, Mraheil MA, Stein M, et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011;11:16.

Kubecova M, Kolostova K, Pinterova D, Kacprzak G, Bobek V. Cimetidine: an anticancer drug? Eur J Pharm Sci. 2011;42(5):439-444.

Kuehn CC, Oliveira LG, Santos CD, Augusto MB, Toldo MP, do Prado JC, Jr. Prior and concomitant dehydroepiandrosterone treatment affects immunologic response of cultured macrophages infected with Trypanosomacruzi in vitro? Vet Parasitol. 2011;177(3-4):242-246.

Kurgat EK, Sexton JD, Garavito F, et al. Impact of a hygiene intervention on virus spread in an office building. Int J Hyg Environ Health. 2019;222(3):479-485.

La Rosa G, Fratini M, Della Libera S, Iaconelli M, Muscillo M. Viral infections acquired indoors through airborne, droplet or contact transmission. Ann Ist Super Sanita. 2013;49(2):124-132.

Lenoir-Wijnkoop I, Merenstein D, Korchagina D, Broholm C, Sanders ME, Tancredi D. Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study. Front Pharmacol. 2019;10:980.

Leung PC. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. Am J Chin Med. 2007;35(4):575-581.

Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics. August 2009 2009;124(2):e172-e179.

Li G, Fan Y, Lai Y, et al. Coronavirus Infections and Immune Responses. J Med Virol. 2020.

Li MJ, Lei JH, Wang T, et al. Cimetidine Enhances the Protective Effect of Gst DNA Vaccine against SchistosomaJaponicum. [In eng] ExpParasitol. 2011 Aug; 128(4): 427-32.

Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. Cochrane Database Syst Rev. 2012;14(3).

Lonnerdal B. Nutritional roles of lactoferrin.CurrOpinClinNutrMetab Care. 2009;12(3):293-297.

MacDonald TT, Bell I. Probiotics and the immune response to vaccines. ProcNutr Soc. 2010;69(3):442-446.

MacIntyre CR, Chughtai AA. Facemasks for the prevention of infection in healthcare and community settings. Bmj. 2015;350:h694.

MacIntyre CR, Zhang Y, Chughtai AA, et al. Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness. BMJ Open. 2016;6(12):e012330.

Maeda H, Ichihashi K, Fujii T, Omura K, Zhu X, Anazawa M, Tazawa K. Oral administration of hydrolyzed rice bran prevents the common cold syndrome in the elderly based on its immunomodulatory action. BioFactors (Oxford, England).2004;21(1-4):185-187.

Maggini S, Beveridge S, and Suter M. A combination of high-dose vitamin C plus zinc for the common cold. J Int Med Res. 2012;40(1):28-42.

Makino S, Ikegami S, Kume A, Horiuchi H, Sasaki H, Orii N. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr. 2010;104(7):998-1006.

Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proceedings of the National Academy of Sciences of the United States of America. Nov 16 2010;107(46):19985-19990.

Mangili A, Vindenes T, Gendreau M. Infectious Risks of Air Travel. Microbiol Spectr. 2015;3(5).

Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017 Feb 15;356:i6583.

Mayo Clinic.Common cold. Last updated Feb. 22, 2011. Accessed 8/17/12 at: http://www.mayoclinic.com/health/common-cold/DS000...

Mayo Clinic.Cough and Cold Combinations (Oral Route). Last updated July 1, 2012. Accessed 7/25/12 at: http://www.mayoclinic.com/health/drug-information/...

McEwan WA, Mallery DL, Rhodes DA, Trowsdale J, James LC.Intracellular antibody-mediated immunity and the role of TRIM21.BioEssays : news and reviews in molecular, cellular and developmental biology. Nov 2011;33(11):803-809.

MD Consult. Dextromethorphan. Available at: http://www.mdconsult.com/das/pharm/body/353603642-... Accessed: 8/24/2012b.

MD Consult. Diphenhydramine. Available at: http://www.mdconsult.com/das/pharm/body/353603642-... Accessed 8/24/2012a.

MD Consult. Influenza. Available at: http://www.mdconsult.com/das/pdxmd/body/353653056-... Accessed. 8/24/2012c.

Mousa HA. Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies. J Evid Based Complementary Altern Med. 2017;22(1):166-174.

Muzembo BA, Ngatu NR, Januka K, et al. Selenium supplementation in HIV-infected individuals: A systematic review of randomized controlled trials. Clin Nutr ESPEN. 2019;34:1-7.

Nahas R, Balla A. Complementary and alternative medicine for prevention and treatment of the common cold. Can Fam Physician. 2011;57(1):31-36.

Naik SR, Hule A. Evaluation of immunomodulatory activity of an extract of andrographolides from Andographispaniculata. Planta Med. 2009;75(8):785-791.

NIAID (National Institute of Allergy and Infectious Diseases). Common Cold: Symptoms. Updated February 11, 2011b. http://www.niaid.nih.gov/topics/commoncold/Pages/s...

NIAID (National Institute of Allergy and Infectious Diseases). Common Cold: Prevention. Last Updated April 13, 2011c. http://www.niaid.nih.gov/topics/commoncold/Pages/p...

NIAID (National Institute of Allergy and Infectious Diseases). Topics: Flu: Understanding Flu: Definitions and Overview. Updated August 08, 2011a. Accessed 7/1/12. Available at: http://www.niaid.nih.gov/topics/Flu/understandingF...

Nicas M, Best D.A study quantifying the hand-to-face contact rate and its potential application to predicting respiratory tract infection. J Occup Environ Hyg. 2008;5(6):347-352.

Niespodziana K, Napora K, Cabauatan C, et al. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. Faseb J. 2012;26(3):1001-1008.

NIH (National Institutes of Health) MedlinePlus: Common Cold. Last updated July 18, 2012. Accessed July 24, 2012b at: http://www.nlm.nih.gov/medlineplus/commoncold.html

NIH (National Institutes of Health) MedlinePlus: Common Cold. Last updated July 27, 2012. Accessed July 30, 2012a at: http://www.nlm.nih.gov/medlineplus/ency/article/00...

Nussenbaum B. (2010) Chapter 13: Pharyngitis in Adults: Common Cold (pg. 196). In: Flint P. (Ed.) Cummings Otolaryngology: Head & Neck Surgery (5th ed.) Mosby, An Imprint of Elsevier.

Oduwole O, Meremikwu MM, Oyo-Ita A, et al. Honey for Acute Cough in Children. [In eng] Cochrane Database Syst Rev. 2012 3(CD007094.

Oklahoma State Dept. of Health. Cold vs. Flu: Know the difference. 09/2011. Available at: http://www.ok.gov/health/documents/Cold vs Flu... Accessed: 8/27/2012.

Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals. 2004;17(3):189-196.

Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92(3):235-250.

Ozgen M, Scheerens JC, Reese RN, Miller RA. Total phenolic, anthocyanin contents and antioxidant capacity of selected elderberry (Sambucuscanadensis L.) accessions.Pharmacogn Mag. 2010;6(23):198-203.

Ozolua RI, Adejayan A, Aigbe OP, Uwaya DO, Argawal A. Some Characteristic Relaxant Effects of Aqueous Leaf Extract of Andrographispaniculata and Andrographolide on Guinea pig Tracheal Rings. Niger J Physiol Sci. 2011;26(2):119-124.

Pae M, Meydani SN, Wu D. The role of nutrition in enhancing immunity in aging. Aging Dis. 2012;3(1):91-129.

Pappas D. (2009) Chapter 28: The Common Cold (pg. 204). In: Long S. (Ed.) Principles and Practice of Pediatric Infectious Diseases Revised Reprint (3rd ed.) Churchill Livingstone, An Imprint of Elsevier.

Paul IM, Beiler J, McMonagle A, et al. Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. [In eng] Arch PediatrAdolesc Med. 2007 Dec; 161(12): 1140-6.

Paules CI, Marston HD, Fauci AS. Coronavirus Infections—More Than Just the Common Cold. JAMA. 2020.

Pence BD, Hester SN, Donovan SM, Woods JA. Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice. Immunol Invest. 2012;41(3):275-289.

Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. Andrographispaniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. J Clin Pharm Ther. 2004;29(1):37-45.

Pourahmad M, and Sobhanian S. Effect of Honey on the Common Cold. [In eng] Arch Med Res. 2009 Apr; 40(3): 224-5.

PRNewswire (2008). Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study. Available at: http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-29-2008/0004822407&EDATE= Accessed 8/22/2012.

Proud D, Reynolds CJ, Lacapra S, et al. Nasal Provocation with Bradykinin Induces Symptoms of Rhinitis and a Sore Throat. [In eng] Am Rev Respir Dis. 1988 Mar; 137(3): 613-6.

Qualls N, Levitt A, Kanade N, et al. Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017. MMWR Recomm Rep. 2017;66(1):1-34.

Reynolds KA, Sexton JD, Pivo T, Humphrey K, Leslie RA, Gerba CP. Microbial transmission in an outpatient clinic and impact of an intervention with an ethanol-based disinfectant. Am J Infect Control. 2019;47(2):128-132.

Romanutti C, Bruttomesso AC, Castilla V, Galagovsky LR, Wachsman MB. Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives.Chemotherapy. 2010;56(2):158-165.

Ross SM. A standardized Echinacea extract demonstrates efficacy in the prevention and treatment of colds in athletes. Holist NursPract. 2010;24(2):107-109.

Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev. 2007;12(1):25-48.

Sandstead HH, Prasad AS. Zinc intake and resistance to H1N1 influenza: Am J Public Health. 2010 Jun;100(6):970-1. Epub 2010 Apr 15.

Saxena RC, Singh R, Kumar P, et al. A randomized double blind placebo controlled clinical evaluation of extract of Andrographispaniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. 2010;17(3-4):178-185.

Scheinfeld N. Cimetidine: a review of the recent developments and reports in cutaneous medicine. Dermatol Online J. 2003;9(2):4.

Shefrin AE, Goldman RD. Use of over-the-counter cough and cold medications in children. Can Fam Physician. 2009;55(11):1081-1083.

Sheahan TP, Sims AC, Graham RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9(396).

Sheahan TP, Sims AC, Leist SR, et al.. Nat Commun. 2020;11(1):222.

Shin JS, Abah U. Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery? Interact CardiovascThorac Surg. 2012;14(5):622-628.

Shiu EYC, Leung NHL, Cowling BJ. Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. Curr Opin Infect Dis. 2019;32(4):372-379.

Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician. 2007;75(4):515-520.

Simon HB. On call. I do my best to exercise every day, either walking two miles in good weather or riding my exercise bike for 30 minutes on wet or cold days. Should I keep going when I catch a cold, or would I be better off resting? HarvMens Health Watch. 2012;16(7):8.

Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2011;16(2):cd001364.

Srinivasan V, Maestroni G, Cardinali D, Esquifino A, Perumal SP, Miller S. Melatonin, immune function and aging. Immunity & Ageing. 2005;2(1):17.

Srinivasan V, Mohamed M, Kato H. Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat EndocrMetab Immune Drug Discov. 2012;6(1):30-

Posted in: Immune support